3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
4
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
240
Carcinoma, Renal Cell
75
Urinary Bladder Neoplasms
56
Kidney Neoplasms
32
Breast Neoplasms
26
Neoplasms
25
Carcinoma, Transitional Cell
22
Neoplasm Metastasis
21
Carcinoma, Non-Small-Cell Lung
14
Sarcoma
11
Non-Muscle Invasive Bladder Neoplasms
11
Lung Neoplasms
11
Melanoma
10
Wilms Tumor
8
Testicular Neoplasms
8
Colorectal Neoplasms
8
Uterine Cervical Neoplasms
7
Urologic Neoplasms
7
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Small Cell Lung Carcinoma
6
Recurrence
6
Ovarian Neoplasms
6
Endometrial Neoplasms
6
Carcinoma, Hepatocellular
6
Carcinoma
6
Prostatic Neoplasms, Castration-Resistant
5
Neuroblastoma
5
Esophageal Neoplasms
5
Interventions
niraparib
1
Prednisone
1
Docetaxel
1
Androgen Antagonists
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
Genitourinary
×
Clear all
NCT06392841
2026-04-08
HARMONY
Hoosier Cancer Research Network
Phase 2
Withdrawn